Data to Decisions: GenAI's Role in Transforming Clinical Trials

About this session

Session: WEDNESDAY AFTERNOON PLENARY SESSION: NEW ERA OF RISK/QUALITY (R3) & LEVERAGING AI TO ACCELERATE TRIALS

Artificial intelligence, data analytics, automation, and technology have the power to connect stakeholders and applications and enhance protocol design, study feasibility, and patient identification and recruitment. The recent explosion of innovation with generative AI is delivering promising advances as we all know. However, this involves constructing a robust data infrastructure, harnessing cutting-edge technologies, adhering to privacy and data security regulations, and enforcing data governance principles.

Speakers

• AP

  Allison Proffitt

  Editorial Dir · Bio-IT World

  Moderator

• DB

  Dorothee B Bartels

  Founder HealthData-Advisors · HeDa-Advisors

  Panelist

• 

  Jonathan Crowther

  Head, Operational Design Center · Merck KGaA, Darmstadt, Germany

  Panelist

• FH

  Farrell Healion

  Founder & Principal Consultant · OptiTrial

  Panelist